Survey: Most Australian Medical Cannabis Patients Use Illicit Market

调查:大多数澳大利亚医用大麻患者使用非法市场

2020-07-18 11:30:41 Ganjapreneur

本文共833个字,阅读需3分钟

Just 3.9 percent of Australians who used cannabis medically last year obtained it legally via prescription and about half of those medical-only consumers were chronic pain patients, according to the nation’s National Drug Strategy Household Survey. In all, about 2.5 million Australians 14-and-older – 11.7 percent – reported using cannabis over the previous year, while 6.8 percent of users said they were using it only for medical purposes, with 16.3 percent saying they used it “sometimes” for medical reasons and “sometimes for other reasons.” Among cannabis users surveyed, support for legalization was overwhelming as 97 percent of recreational users (those that did not use for medical purposes) supported the reforms, along with 89 percent of respondents who used cannabis only for medical reasons, and 87 percent of users who used cannabis medically “sometimes.” In all, 41 percent of Australians backed legalization, while 44 percent said they approved “increased penalties” for cannabis sales. The survey also found just 20 percent of Australians approved of “regular” cannabis use by adults, compared to 82 percent of non-medical users, 72 percent of medical-only users, and 65 percent of those that used cannabis medically sometimes. Older folks were also more likely to use cannabis only for medical purposes, as 43 percent of medical-only users were 50-or-older; 14.4 percent were aged 40-49, 16.1 percent were 30-39, and 26 percent were 14-29. The majority of non-medical users – 69 percent – were younger than 40, while 15.4 percent of recreational consumers were 40-49, 10.5 percent were 50-59, while 5.5 percent were 60-plus. The same sub-40 demographic was also more likely to “sometimes” use cannabis medically at 66 percent, along with 27 percent of 30-39-year-olds, 15.8 percent of those 40-49, 14 percent aged 50-59, and 4.9 percent aged 60-and-older. Overall, the survey saw small increases in lifetime and recent cannabis use from 2018 to 2019, from 35 percent to 36 percent and 10.4 percent to 11.6 percent, respectively. Australia legalized medical cannabis nationally in 2016. According to the Australian Department of Health, 15,566 patients are estimated to have accessed medical cannabis last year, a massive increase from the 2,526 estimated to have accessed the program in 2018. A Prohibition Partners analysis in April suggested that a legal Oceania cannabis market – which includes Australia, New Zealand, Guam, and the surrounding islands – could be worth $1.55 billion by 2024, with 40 percent of the market comprised of medical cannabis sales.
根据国家药品战略家庭调查,去年,仅有3.9%使用大麻的澳大利亚人通过处方合法获得大麻,其中大约一半只使用大麻的消费者是慢性疼痛患者。总共约250万名14岁以上的澳大利亚人(11.7%)报告说,去年使用大麻,而6.8%的用户表示他们只将大麻用于医疗目的,16.3%的用户表示,他们“有时”出于医疗原因,“有时”出于其他原因使用大麻。 在接受调查的大麻使用者中,对合法化的支持是压倒性的,因为97%的娱乐使用者(不用于医疗目的的)支持改革,89%的受访者仅出于医疗原因使用大麻,87%的人“有时”使用大麻。总之,41%的澳大利亚人支持合法化,44%的人表示他们批准了大麻销售的“更多处罚”。 调查还发现,只有20%的澳大利亚人同意成年人使用“常规”大麻,而非医疗使用者的比例为82%,医疗使用者的比例为72%,有时使用大麻的比例为65%。 老年人也更有可能只为医疗目的使用大麻,因为43%的只使用大麻的人是50岁或50岁以上;14.4%的人是40-49岁,16.1%是30-39岁,26%是14-29岁。 大多数非医疗用户(69%)年龄在40岁以下,15.4%的休闲消费者是40-49岁,10.5%是50-59岁,5.5%是60%以上。同样,40岁以下的人群“有时”更有可能以66%的医疗水平使用大麻,30-39岁的人群中有27%,40-49岁的人群中有15.8%,50-59岁的人群中有14%,60岁以上的人群中有4.9%。 总体而言,调查显示,2018年至2019年,大麻的使用寿命和近期增幅较小,分别从35%至36%和10.4%增至11.6%。 2016年,澳大利亚将全国医用大麻合法化。据澳大利亚卫生部统计,去年估计有1566名患者获得了医用大麻,比2018年估计获得该项目的2526人大幅增加。 禁止合作伙伴4月份的一项分析显示,到2024年,合法的大洋洲大麻市场(包括澳大利亚、新西兰、关岛和周边岛屿)价值15.5亿美元,其中40%的市场由医用大麻销售构成。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文